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Renal Na-phosphate cotransporter gene expression in X-linked Hyp
and Gy mice. The X-linked Hyp and Gy mutations are murine homologues
of X-linked hypophosphatemia (XLH), a dominant disorder of phosphate
(Pi) homeostasis characterized by growth retardation, rickets, hypophos-
phatemia and decreased renal tubular maximum for Pi reabsorption
relative to glomerular filtration rate (Tm0/GFR). In Hyp and Gy mice, the
decrease in TmJGFR is associated with a reduction in renal brush-border
membrane (BBM) Na-Pi cotransport that can be ascribed to a decrease
in renal-specific, Na-Pi cotransporter (NPT2) mRNA and protein abun-
dance. Although renal NPT2 gene expression is reduced in Hyp and Gy
mice, the NPT2 gene does not map to the X chromosome. These findings
exclude NPT2 as a candidate gene for murine and human X-linked
hypophosphatemias and suggest that genes at the Hyp, Gy and XLH
(HYP) loci are involved in regulation of NPT2 gene expression. Both Hyp
and Gy mice respond to low Pi diet with an increase in BBM Na-Pi
cotransport, NPT2 mRNA and protein. The increase in NPT2 protein in
Pi-depleted mice far exceeds the increase in NPT2 mRNA, suggesting that
translational or post-translational mechanisms are involved in the adaptive
process. NPT2 protein is localized to the apical surface of the proximal
tubule, where immunostaining in both normal and Hyp mice is increased
in response to low Pi diet. Pi-deprived Hyp and Gy mice fail to show an
increase in Tm/GFR, indicating that adaptation at the BBM is not
sufficient for the overall increase in Tm1,IGFR in response to low Pi diet.
Several Mendelian disorders of phosphate (Pi) homeostasis
have been described in humans [1]. These include X-linked
hypophosphatemia (XLH), hereditary hypophosphatemic rickets
with hypercalciuria (HHRH) and hypophosphatemic bone disease
(HBD) [2]. Although the three disorders are characterized by
renal Pi wasting, hypophosphatemia and bone disease, they can be
distinguished by their mode of inheritance, the severity of the
bone disease and the ability of renal enzymes involved in vitamin
D metabolism to respond to the hypophosphatemic signal [2].
XLH is the most prevalent of the three disorders and studies of
renal Pi transport in murine Hyp and Gy homologues of XLH will
be the focus of the present review. Nevertheless, we have an
abiding interest in HHRH and HBD since genes that encode
renal-specific Na -Pi cotransporters and map to autosomes may
be candidate genes for these disorders.
XLH, first described in 1937 by Aibright, Butler and Bloomberg
[3], is characterized by rickets and osteomalacia, decreased
growth rate, shortened stature and hypophosphatemia arising
from impaired renal reabsorption of filtered Pi. The renal Pi leak
in XLH is not secondary to hyperparathyroidism since serum
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calcium levels and parathyroid gland function are normal in XLH
patients [4]. The serum concentration of 1,25-dihydroxyvitamin D
[1 ,25-(OH)2D], the active hormonal form of vitamin D, is also
normal in XLH. However, because hypophosphatemia is an
important regulatory signal for increased renal 1,25-(OH)2D
production, the circulating concentration of the vitamin D hor-
mone is inappropriate for the serum Pi concentration in XLH [5].
These data suggest that, in addition to the defect in Pi reabsorp-
tion, the regulation of renal 1,25-(OH)2D synthesis and/or catab-
olism is impaired in XLH. The mode of inheritance is X-linked
dominant when hypophosphatemia is used as the inherited phe-
notypic discriminant [6]. The XLH locus, designated HYP, has
been mapped by linkage analysis to Xp22.1-p22.2 [71 and posi-
tional cloning initiatives [8] have led to the identification of a
candidate gene (see Econs in this issue). Much of our knowledge
of the pathophysiology of XLH has been derived from studies of
the murine homologues Hyp and Gy, which, like XLH, are
characterized by bone changes resembling rickets, dwarfism and
hypophosphatemia associated with high fractional excretion of
filtered Pi (Fig. 1) [9, 10].
Hyp and Gy mouse models
The Hyp mutation arose spontaneously at the Jackson Labora-
tory [9], while the Gy mutation first originated in the female
offspring of a dam that was subjected to X-irradiation [10].
Although both Hyp and Gy mice exhibit hypophosphatemia, renal
Pi wasting and rachitic bone disease, several phenotypic features
distinguish the mutant strains. These include circling behavior,
hyperactivity, abnormalities in the inner ear and deafness which
are present in Gy but not in Hyp mice [10]. Another significant
difference between Hyp and Gy relates to the effect of gene dose
on the expression of the mutant phenotype. In Hyp mice, metrical
traits [tail length, serum Pi and renal brush border membrane
(BBM) Na-Pi cotransport (see Renal Pi transport in Hyp and Gy
mice)] are similar, and significantly lower than normal, in het-
erozygous females (HypI+), homozygous females (Hyp/Hyp) and
hemizygous males (HyplY), findings that are not typical for
X-linked disorders [11—13]. Moreover, bone histomorphometric
abnormalities are of similar magnitude in Hyp/Y, HypI+ and
Hyp/Hyp mice (Z.Q. Qiu, R. Travers, F.H. Glorieux, H.S. Tenen-
house and C.R. Scriver, manuscript in preparation). In contrast,
an obvious gene dose effect is evident in Gy mice; hemizygous Gy
males (GyIY) are more severely affected than heterozygous
females (Gy/+) and do not survive on the C57BL/6J background
[14]. Moreover, on the hybrid B6C3H background, femoral
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It is ell kno n that the bulk of filtered Pi is reabsorbed in the
proxi al tubule here the rate li iting step in the transepithelial
transport process is ediated by a 1 -Pi cotransporters that
reside in the  [ ]. cc r i ly, to delineate the ec a is
for renal Pi wasting in Hyp and Gy mice, we compared initial rate
Na -dependent Pi uptake in renal BBM vesieles prepared from
the normal and mutant strains. As depicted in Figure 3, BBM
Na-Pi cotransport is 50% of normal in Hyp and Gy mice. The
specificity of the transport defect for Pi was demonstrated by the
presence of normal Na -alanine (Fig. 3) and Nat-glucose co-
transport [17—19] in BBMs of both mutant strains. The Pi
transport defect in Hyp mice was localized to the proximal tubule
[20, 21]; it is independent of PTH status [21, 22] and not expressed
in the intestinal BBM [23].
Kinetic studies revealed that both low affinity-high capacity and
high affinity-low capacity Pi transport systems are expressed in
BBM of !Iyp mice, but that only the high affinity transport system
is impaired, with a 50% decrease in V, and no change in
apparent K,,1 for Pi [24]. Gy mice also exhibit a reduction in Vrnax
of the high affinity Pi transport system [19]. These findings
underscore the importance of the high affinity Pi transport system
in the overall maintenance in Pi homeostasis, since a defect in this
system is sufficient cause for hypophosphatemia and bone disease.
Fig. 2. Schematic representation of the (A) human and (B) mouse X
chromosomes. Genes which have been localized to each of five homolo-
gous (syntenic) regions that are rearranged and, in some cases, inverted
are shown. Abbreviations are: STS, steroid sulfatase; DMD, Duehenne
muscular dystrophy; OTC, ornithine transcarbamylase; GLA, a-galactosi-
dase (PGK 1, phosphoglycerokinase 1); HPRT, hypoxanthine phosphori-
bosyltransferase. The loci for human (IJYP) and murine (Hyp and Gy)
X-linked hypophosphatemias are shown.
The radiation inactivation size of the Na-Pi cotransporter in
Hyp mice (227 39 kDa) is similar to that in normal littermates
(242 16 kDa) [25]. In addition, the BBM Pi transport defect in
Hyp mice cannot be ascribed to an abnormal response of the
cotransporter to the Nat-gradient driving force, membrane po-
tential or pH [26]. These results are consistent with the notion
that an abnormality in the cotransporter per se does not account
for the BBM Pi cotransport defect in Hyp mice.
The recent cloning of cDNAs encoding two distinct renal-
specific Na -Pi eotransporters, NPTI [27—29] and NPT2 [30—32]
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Fig. 3. Effect of the Hyp and Gy mutations on
renal BBM (A) Na-Pi and (B) Na-alanine
cotransport. Initial rate Na-dependent Pi and
alanine uptakes were measured in BBM vesicles
purified from the renal cortex of normal, Hyp
and Gy mice. Data are taken from [10]. *Eflect
of genotype, P < 0.001.
t t  termine the chromosomal localization of the NPT2
. i  luorescence in situ hybridization, the NPT2 gene was
 t  human chromosome 5q35 [35], a finding that was
fir ed by PCR amplification of DNA from a chromosome 5
ion pa el [36] and a chromosome 5 radiation hybrid panel,
i  2-specific primers (J.D. McPherson, C.H. Kos and H.S.
, manuscript in preparation). Our results thus exclude
T2 as a candidate gene for the homologous human and murine
-linked hypophosphatemias [35], and suggest that the genes at
linke  J-Iyp/Gy/HYP loci do not encode NPT2 but rather are
lved in the regulation of cotransporter gene expression. The
z ion of NPT2 to human chromosome 5q35 [35] and NPT1
romosome 6p2l.3-p23 [28] suggests that NPT2 and
1 may be candidate genes for HHRH and HBD, both of
ich are a tosomal disorders of renal Pi reabsorption.
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Fig. 4. Effect of the Hyp and Gy mutations on renal Na -Pi cotransport
V,,, and abundance of NPT2 immunoreactive protein. Renal BBM vesicles
were prepared for kinetic studies [24] and Western analysis [33] as
described previously. Data are taken from [19, 24, 33, 34]. *Effect of
genotype, P < 0.01.
from a variety of species led to the development of eDNA probes
and antibodies to quantitate the molecular entities which deter-
mine transport function and to examine the mechanism for the
BBM Pi transport defects in Hyp and Gy mice. We demonstrated
that the abundance of renal NPT2 immunoreactive protein is
significantly reduced in Hyp [33] and Gy mice [34] relative to
normal littermates, and that the reduction is proportional to the
reduction in transport V,,ax (Fig. 4). In addition, we showed that
NPT2 mRNA abundance, relative to /3-actin mRNA or 18S RNA,
is proportionately reduced in Hyp [33] (Fig. 5) and Gy mice [34].
These data indicate that the number of high affinity NPT2 Na-Pi
cotransport sites is significantly reduced in the renal BBM of both
mutant strains by a mechanism that involves decreased NPT2
gene transcription and/or decreased NPT2 mRNA stability.
Chromosomal localization of NPT2
To understand the relationship between reduced renal NPT2
gene expression and the X-linked Hyp and Gy mutations, we
Studies in our laboratory demonstrated that, in spite of de-
creased renal NPT2 gene expression, Hyp [24, 37] and Gy [19]
mice respond to low Pi diet with an adaptive increase in renal
BBM Na-Pi cotransport (Fig. 6). The defect in Na-Pi cotrans-
port continues to be manifest in P1-deprived Hyp and Gy mice
when compared to P1-deprived normal littermates (Fig. 6). We
showed that the increase in Na-Pi cotransport was associated
with an increase in the abundance of BBM NPT2 protein, relative
to meprin, an abundant renal BBM endopeptidase, in normal (1
0.1 to 8.8 2.4), Hyp (0.3 0.1 to 7.7 1.5) and Gy mice (0.5
0.1 to 7.8 3.0) [34, 38]. An unexpected finding was that NPT2
protein abundance is similar in BBMs of Pi-deprived normal, Hyp
and Gy mice despite the persistence of the Pi transport defect
under these conditions (Fig. 6). While the basis for the discrep-
ancy between functional activity and NPT2 protein abundance in
mice fed the low Pi diet is not clear, the data suggest that a portion
of newly synthesized NPT2 protein in the BBM of the mutant
strains is present in a form that is not fully active. The latter may
be ascribed to incomplete or altered post-translational modifica-
tion of newly synthesized NPT2 protein in the mutant strains. A
possible explanation for our findings is that protein kinase C
activity is significantly decreased in renal BBMs upon the admin-
istration of low Pi diet to normal, but not to Hyp, mice [39] and
that activation of protein kinase C by phorbol myristate acetate
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Fig. 5. Northern blot analysis of total RNA
extracted from kidneys of normal and Hyp mice.
Blots were probed with 32P-labeled NaPi-2 (rat
NPT2) and -actin cDNA probes. The NaPi-2/
j3-actin ratios were obtained by densitometric
analysis of 6 RNA samples in each group.
Ratios are significantly different between
normal and Hyp mice (P < 0.01). Figure is
taken from [331 with permission.
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Fig. 6. Effect of low Pi diet on Na -Pi cotransport in renal BBM vesicles
from normal, Hyp and Gy mice. Mice were fed control and low Pi diets for
five days. Renal BBM vesicles were isolated and Pi transport studies
performed as described previously [24]. 100% represents Na-Pi cotrans-
port in renal BBM vesicles from normal mice fed the control diet. Data are
obtained from [34, 38]. *Effect of genotype, P < 0.01; #effect of diet, P <
0.01.
inhibits Na-Pi cotransport in proximal tubular cells from normal
mice [40]. Whether higher protein kinase C activity in BBMs of
Pi-deprived Hyp mice, relative to Pi-deprived normal littermates
[39], is responsible for differences in the phosphorylation state of
the Na-Pi cotransporter or a functionally related protein and
thereby accounts for the differences in transport function will
require further investigation.
Immunoperoxidase staining of renal sections from normal and
Hyp mice demonstrated that NPT2 protein is localized exclusively
to the apical surface of proximal tubular cells and that both the
intensity of the signal and the number of immunostained proximal
tubules are increased after feeding the low Pi diet [381. The
specificity of NPT2 immunostaining was demonstrated by the
absence of a signal with preimmune serum [38]. The specificity of
the NPT2 response to low Pi diet was demonstrated by the finding
that immunostaining of meprin was not increased in renal sections
from Pi-depleted normal or Hyp mice [38].
The increase in Na-Pi cotransport and NPT2 protein was
accompanied by a modest (< twofold) but significant increase in
the relative abundance of NPT2 mRNA in normal, Hyp [38] and
Gy mice [34]. The magnitude of the increase in NPT2 mRNA was
markedly less than the increase in immunoreactive protein, sug-
gesting that translational or post-translational mechanisms are
involved in the adaptation process. Similar findings were reported
in Pi-deprived rats [41, 42].
It is of interest that neither Hyp [43] nor Gy [44] mice exhibit an
adaptive increase in renal tubular maximum for Pi reabsorption
relative to glomerular filtration rate (Tm/GFR) in response to Pi
deprivation. Our results thus indicate that the increase Na-Pi
cotransport at the BBM of the proximal tubule is not sufficient for
the overall increase in Tm/GFR in the kidney as a whole. We
suggest that the adaptive increase in Tm/GFR requires mecha-
nisms and/or targets other than the BBM. Indeed, evidence has
been provided for increased distal tubular Pi reabsorption in rats
fed a low Pi diet [45—47]. In addition, we postulate that 1,25-
(OH)2D may be necessary for the adaptive increase in Tm/GFR.
This is based on the demonstration that Pi depletion elicits a
precipitous fall in serum 1,25-(OH)2D levels in Hyp [48] and Gy
[19] mice that is the direct result of increased renal catabolism of
the vitamin D hormone in the mutant strains [19, 481, while in
normal mice, Pi depletion stimulates renal 1,25-(OH)2D synthe-
sis, resulting in increased circulating levels of the vitamin D
hormone [19, 48, 49].
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Conclusion
Studies in X-linked Hyp and Gy mice have elucidated the
underlying mechanism for the renal P1 leak in the homologous
murine and human X-linked hypophosphatemias. These investi-
gations demonstrate that, despite significant down-regulation of
renal NPT2 gene expression in the mutant mouse strains, this
renal Na-Pi cotransporter gene is not a candidate gene for Hyp
and Gy. it is clear, however, that the decrease in renal NPT2 gene
expression is responsible for the hypophosphatemia and contrib-
utes to the hone abnormalities in Hyp, Gy and XLH. Accordingly,
NPT2 may serve as an important target for the development of
new therapeutic strategies in the treatment of XLH.
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